Plavix 75 mg — Class III drug recall D-317-2013
Terminated recall by Physicians Total Care, Inc., reported 2013-05-15, distributed in NC. Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).
| Recall number | D-317-2013 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Physicians Total Care, Inc., Tulsa, OK, United States |
| Recall initiated | 2011-02-08 |
| Classified | 2013-05-09 |
| Reported by FDA | 2013-05-15 |
| Terminated | 2013-07-01 |
| Distributed | NC |
| Quantity | 60 tablets |
| Reason classes | chemical contamination |
| NDC | 54868-4070-00 |
| Lot numbers | 08/13, 67JV |
Product
Plavix 75 mg, 30 count bottle, NDC (54868-4070-0), Rx only, Manufactured by Bristol-Meyers Squibb, Bridgewater, NJ 08807, Distributed by Physicians Total Care, Tulsa, OK 74146.
Reason for recall
Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-317-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.